# 2care4 ApS Company profile · SME (from the award notice) - Legal form: A/S - Seat: Esbjerg V, Denmark - Also named in notices: 2care4 Aps Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 December 2025. ## Identifiers Not found in the indexed notices. ## Track record in public tenders Awards in the covered notices over the last 36 months, per CPV division. | CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award | | --- | ---: | ---: | ---: | ---: | --- | --- | | 33 Medical equipments, pharmaceuticals and personal care products | 3 | — | 1 | 1 | 1 October 2024 | 1 December 2025 | Based on the notices and sources Inteliwert covers; not a complete record. ### Awards - [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi) Buyer: DAK-Gesundheit · Awarded: 1 December 2025 · CPV 33600000 - [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 für die Zeit 01.10.2024 - 30.09.2026](https://inteliwert.com/tender/opp_PVM8MRN4TB7T2AG6K9H1JH3Q56/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum) Buyer: DAK-Gesundheit · Awarded: 1 October 2024 · CPV 33600000 - [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Faricimab, ATC S01LA09 für die Zeit 01.10.2024 - 30.09.2026](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum) Buyer: DAK-Gesundheit · Awarded: 1 October 2024 · CPV 33600000 ## Certifications and prequalification No certification or prequalification found in the covered sources. A certification missing here is unknown, not absent. ## Website and LinkedIn Not found in the indexed notices. ## Open tenders that might fit *Possible match based on public information* Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances. - [1/DLII6/VM131 - RV div. Arzneimittel](https://inteliwert.com/tender/opp_ABQEJFE6RGWB1YMRSGTEVP7BNJ/1-dlii6-vm131-rv-div-arzneimittel) Open · SME (from the award notice) · Buyer: Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr · Deadline: 23 Nov 2026, 08:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/a168497c-ebf2-4cd1-b31b-1bb6bd6b9a95), Last checked 4 Nov 2026, 16:10 (UTC+01:00) - Won a contract in CPV group 336 (2025-12-01): [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - 3 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - [Dynamisches Beschaffungssystem Arzneimittel](https://inteliwert.com/tender/opp_JWTTBX70N6HNDKYZ69CV2SV10S/dynamisches-beschaffungssystem-arzneimittel) Open · SME (from the award notice) · Buyer: Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/ce95a438-562e-4a68-87cb-032645a33fcf), Last checked 9 Nov 2026, 03:31 (UTC+01:00) - Won a contract in CPV group 336 (2025-12-01): [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - 3 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - [Open-House-Rabattverträge 2026-21 Lisdexamfetamin (90 St.)](https://inteliwert.com/tender/opp_5V97787MV6AN17BB79FJWVV6FY/open-house-rabattvertraege-2026-21-lisdexamfetamin-90-st) Open · SME (from the award notice) · Buyer: Techniker Krankenkasse · Deadline: 31 Mar 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/11d66e3b-2f29-4ea1-8371-be1eb4a372e6), Last checked 4 Nov 2026, 13:10 (UTC+01:00) - Won a contract in CPV group 336 (2025-12-01): [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat outside the country of performance: [Evidence](https://inteliwert.com/company/org_BSYE7PYT62Z99FWKCDZ0VAMDZS), checked 8 Nov 2026 - 3 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Testkits zum molekularbiologischen Nachweis des Virus der Afrikanischen Schweinepest, der Europäischen Schweinepest sowie der Blauzungenkrankheit mittels real-time PCR](https://inteliwert.com/tender/opp_5QPA0VBQ12QX0TK63V2BH2FEHE/testkits-zum-molekularbiologischen-nachweis-des-virus-der-afrikanischen-schweine) Open · SME (from the award notice) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/43a355eefccb611a), Last checked 7 Nov 2026, 14:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-10-01): [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - [1/DLII6/VM154 - RV Arzneimittel, divers](https://inteliwert.com/tender/opp_8R9W8QYRP9E590QKT35CYZM99Q/1-dlii6-vm154-rv-arzneimittel-divers) Open · SME (from the award notice) · Buyer: Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr · Deadline: 5 Nov 2026, 08:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/45ef0c52-8603-431b-a2d1-53252a27e326), Last checked 6 Nov 2026, 21:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-10-01): [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_9788MB2MCR6E6M0032PSDN9T3E/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Aug 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/aeccaeda-3877-4fde-b8f3-00d0be3af035), Last checked 7 Nov 2026, 13:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-10-01): [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - [Open-House-Verträge 2026-3](https://inteliwert.com/tender/opp_WN8C4T3XWFJZ2X1C262PQB8P1V/open-house-vertraege-2026-3) Open · SME (from the award notice) · Buyer: AOK Bremen/Bremerhaven · Deadline: 30 Sept 2028, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/7b4b4214-8586-429e-afe6-2f785a1790c4), Last checked 7 Nov 2026, 22:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-10-01): [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - [Open-House-Verträge 2026 - Aflibercept (Kopie)](https://inteliwert.com/tender/opp_310G288E927DFJX9GGTNKDRSMA/open-house-vertraege-2026-aflibercept-kopie) Open · SME (from the award notice) · Buyer: AOK Bremen/Bremerhaven · Deadline: 5 Oct 2028, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/77b0cf91-da10-4256-a964-60001e4b6e7e), Last checked 7 Nov 2026, 04:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-10-01): [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_ZBCA5WCXTGPHJZQT2AJPKANS8E/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026 - [Open House Originale Rabattverträge 2025-05 - Emtricitabin/Tenofovirdisoproxil/Rilpivirin (Wirkstoffkombination)](https://inteliwert.com/tender/opp_SE9778W0M0TDWPM20QNS2PM3VS/open-house-originale-rabattvertraege-2025-05-emtricitabin-tenofovirdisoproxil-ri) Open · SME (from the award notice) · Buyer: Techniker Krankenkasse · Deadline: 30 Nov 2026, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/581490b8-248a-4903-bcf9-93fbed29074c), Last checked 9 Nov 2026, 03:31 (UTC+01:00) - Won a contract in CPV group 336 (2025-12-01): [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - Seat outside the country of performance: [Evidence](https://inteliwert.com/company/org_BSYE7PYT62Z99FWKCDZ0VAMDZS), checked 9 Nov 2026 - 3 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - [Open house Arzneimittelrabattverträge zum Wirkstoff Dimethylfumarat, ATC L04AX07](https://inteliwert.com/tender/opp_7YFQQXA9N423S2WZ6E41MN4BKJ/open-house-arzneimittelrabattvertraege-zum-wirkstoff-dimethylfumarat-atc-l04ax07) Open · SME (from the award notice) · Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Deadline: 31 Jan 2027, 23:59 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/789560c2-abe9-4d86-bf75-7afdd46d030c), Last checked 8 Nov 2026, 08:30 (UTC+01:00) - Won a contract in CPV group 336 (2025-12-01): [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat outside the country of performance: [Evidence](https://inteliwert.com/company/org_BSYE7PYT62Z99FWKCDZ0VAMDZS), checked 8 Nov 2026 - 3 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_JTVBRGPNJYNFM0KZJB1ND89SBQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 ## Is this your company? Send corrections, or ask us to remove the profile, to . You can also ask that the company never be tagged on LinkedIn. ## About this profile Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances. **Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 December 2025. --- Page: https://inteliwert.com/company/org_BSYE7PYT62Z99FWKCDZ0VAMDZS/2care4-aps Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert. Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.